LOS ANGELES—Talent Testing Service (TTS), the adult industry's leading provider of STD testing, is pleased to announce its June 2025 update featuring the latest positivity rates.
Overall, the three Chlamydia Urine rates exhibit similar trends over time, including a steady decline since the peak in November 2022.
In June 2025, all three rates increased: the Total rate to 1.2% from 1.0%, the Male rate to 1.3% from 1.0%, and the Female rate to 1.1% from 0.9%. Given that historic levels have been around 2.0%, the current rates can still be considered within expectations.
In June 2025, the Trichomonas Vaginalis Urine rates showed fluctuations: the Total rate declined to 0.3% from 0.4%, the Male rate increased slightly to 0.2% from 0.1%, and the Female rate dropped to 0.4% from 0.7%. These current levels remain within the general range of 0.0% to 1.5%.
In June 2025, all Mycoplasma G. Urine rates trended downward: the Female rate to 3.3% from 4.3%, the Total rate to 3.1% from 3.7%, and the Male rate to 2.8% from 3.2%.
Based on market activity, the positivity rates for the four tests below have December 2022 as a relevant starting point, where all levels display their peak and then start overall downward trends. In June 2025, the Chlamydia Rectal rates show that only the Total rate remained at 1.1%, while the Female rate just went up to 1.2%, and the Male rate went down to 1.0%. The Chlamydia Throat rates all dropped to 0.0%, the Male rate from 0.4%, the Female rate from 0.8%, and the Total rate from 0.6%.
Although within an overall smaller range of 0.0% to 3.5%, when compared to the other swab rates, the Gonorrhea Rectal lines volatility is visible since April 2023, and in June 2025 decreased further, the Female rate to 0.5% from 1.0%, the Total rate to 0.4% from 0.9%, and the Male rate to 0.1% from 0.9%.
The Gonorrhea Throat rates have the Male rate returning to 1.2% from 0.8%, the Total rate again a tick lower to 0.9% from 1.0%, and the Female rate further down to 0.7% from 1.2%. In conclusion, the rate levels displayed in the Gonorrhea Rectal swabs continue to show a more volatile behavior than the other three swab tests.
This TTS blog post is available here.
